Degenerative Brain Disorder (DBCOND0105850)

Identifiers

Synonyms

Degenerative brain disorder / Cerebral degeneration / Cerebral degeneration (disorder) / Cerebral degeneration, unspecified / Degenerative brain disorder (disorder)

Associated Data

Indicated Drugs and Targets

Drug	Description	Targets
Aniracetam	A nootropic drug used to ameliorate memory and attention disturbances accompanying cerebrovascular diseases and degenerative brain disorders.	5-hydroxytryptamine receptor 2Atarget D(2) dopamine receptortarget Glutamate receptor 2target Glutamate receptor 3target
Choline alfoscerate	A natural choline that is used to manage declining cognitive function associated with neurodegenerative and vascular diseases.	Ganglioside GM2 activatortarget Muscarinic acetylcholine receptor M5target
Citicoline	An endogenous intermediate in the formation of phosphatidylcholine from choline which is thought to have neuroprotective effects.	LicC proteintarget

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT03414333	To Determine the Effect of GLP1 on Cognitive Function, Brain Glucose Metabolism and Neuroplasticity.	No drug interventions	treatment	Not Available	completed